TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.
Alessandro D Santin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.